CJC-1295 Without DAC + Ipamorelin 10mg
$126.00
CJC-1295 Without DAC + Ipamorelin 10mg by LP Peptides is a lyophilized research peptide formulation combining two compounds studied in growth hormone signaling, endocrine research, peptide-receptor interactions, and cellular signaling. Supplied for qualified laboratory research with product and batch documentation, this formulation is not intended for human or veterinary use.
CJC-1295 Without DAC + Ipamorelin 10mg – Research Peptide Blend
| Product Information | Details |
|---|---|
| Product Name | CJC-1295 Without DAC + Ipamorelin 10mg |
| Brand | LP Peptides |
| SKU | CJCIP10 |
| Category | Growth Hormone & Peptide Research |
| Research Compounds | CJC-1295 Without DAC + Ipamorelin |
| Specification | 10mg × 10 Vials / Box |
| Form | Lyophilized Powder |
| Availability | Research Use Only |
| Price | Contact for Current Pricing |
What is CJC-1295 Without DAC + Ipamorelin 10mg?
CJC-1295 Without DAC + Ipamorelin 10mg (CJCIP10) is a combination research peptide formulation supplied by LP Peptides for qualified laboratory research.
CJC-1295 without DAC is a growth hormone-releasing hormone (GHRH) analog studied for its interaction with GHRH-related signaling, while Ipamorelin is a growth hormone secretagogue investigated for its activity at the growth hormone secretagogue receptor (GHSR).
The combination is commonly studied in research involving growth hormone signaling, endocrine pathways, peptide-receptor interactions, metabolic regulation, and cellular signaling. Research applications should be conducted using validated laboratory protocols and appropriate experimental controls.
LP Peptides supplies CJCIP10 as a lyophilized research formulation with product and batch documentation intended exclusively for qualified laboratory research.
Product Specifications
| Specification | Details |
| Product | CJC-1295 Without DAC + Ipamorelin 10mg |
| SKU | CJCIP10 |
| Brand | LP Peptides |
| Compounds | CJC-1295 Without DAC + Ipamorelin |
| Total Strength | 10mg |
| Packaging | 10mg × 10 Vials / Box |
| Form | Lyophilized Powder |
| Category | Growth Hormone & Peptide Research |
| Intended Use | Laboratory Research Only |
Research Applications
This combination may be investigated in laboratory research involving:
- Growth hormone signaling
- GHRH receptor pathways
- Growth hormone secretagogue signaling
- GHSR receptor research
- Endocrine signaling
- Peptide-receptor interactions
- Metabolic research
- Cellular signaling
- Hormone pathway research
- Molecular biology
- Peptide pharmacology
Research should be conducted according to validated laboratory protocols, appropriate controls, and applicable institutional requirements.
Research Context
CJC-1295 without DAC and Ipamorelin are studied through different but related signaling mechanisms.
CJC-1295 without DAC is investigated as a GHRH analog, while Ipamorelin is studied as a selective growth hormone secretagogue. Researchers may examine their individual and combined effects on growth hormone-related signaling and downstream biological pathways.
The scientific literature surrounding these compounds varies by experimental model, and research findings should not be interpreted as evidence of established therapeutic efficacy.
Frequently Compared Research Products
Researchers may compare CJCIP10 with related research compounds, including:
| Related Products |
| CJC-1295 |
| Ipamorelin |
| CJC-1295 + Ipamorelin blends |
| Tesamorelin 10mg |
| MOTS-C 10mg |
| NAD+ 500mg |
Each compound should be evaluated independently according to the defined research objective and experimental design.
Laboratory Handling
CJCIP10 is supplied as a lyophilized powder.
For laboratory handling:
- Follow the current product documentation and laboratory SOP.
- Use appropriate laboratory handling procedures.
- Maintain accurate batch and inventory records.
- Document preparation and experimental conditions where applicable.
- Avoid unnecessary exposure to heat, moisture, and light.
- Review the applicable COA and product documentation before research use.
Specific preparation requirements should be determined by the qualified laboratory and its validated protocol rather than relying on generalized human-use instructions.
Storage Guidelines
| Storage Condition | Recommendation |
| Lyophilized Product | Store according to the current lot-specific documentation. |
| Environmental Conditions | Keep dry and protected from excessive heat and light. |
| Handling | Minimize unnecessary exposure to environmental conditions during handling. |
| Documentation | Follow the current COA, product record, and laboratory SOP. |
Lot-specific storage requirements should take precedence over general product-page guidance.
Research Safety Information
CJC-1295 without DAC and Ipamorelin are investigational research compounds.
Laboratory investigations may examine:
- Growth hormone pathway activity
- Endocrine signaling
- GHRH-related pathways
- GHSR signaling
- Peptide-receptor interactions
- Metabolic signaling
- Cellular responses
Researchers should evaluate the current scientific literature, applicable safety documentation, and institutional procedures before beginning an experiment.
Research Use Disclaimer
CJCIP10 supplied by LP Peptides is intended strictly for qualified laboratory research purposes.
This product:
- Is not intended for human use.
- Is not intended for veterinary use.
- Is not intended for consumption.
- Is not a drug or approved therapeutic product.
- Should only be handled by appropriately qualified research personnel.
Information provided on this page is for scientific reference and product identification only and should not be interpreted as medical advice or a therapeutic claim.
COA & Quality Assurance
Researchers should verify each batch using the applicable LP Peptides documentation.
| Quality Checklist |
| Certificate of Analysis (COA) |
| Product identity |
| Batch number |
| Testing date |
| Assay or purity information where applicable |
| Product specification |
| Packaging information |
| Storage requirements |
| Applicable quality-control records |
The current lot-specific documentation should always take precedence over general catalog information.
Frequently Asked Questions
| Question | Answer |
| What is CJCIP10? | CJCIP10 is an LP Peptides research formulation containing CJC-1295 without DAC and Ipamorelin, supplied as a lyophilized research product. |
| What is CJC-1295 without DAC studied for? | It is investigated as a GHRH analog in studies involving growth hormone-related signaling and endocrine pathways. |
| What is Ipamorelin? | Ipamorelin is a peptide studied for its activity at the growth hormone secretagogue receptor and related signaling pathways. |
| What research areas are relevant to this combination? | Research may focus on growth hormone signaling, endocrine pathways, peptide-receptor interactions, metabolic signaling, and cellular biology. |
| Is CJCIP10 intended for human use? | No. It is supplied strictly for qualified laboratory research and is not intended for human or veterinary use. |
| How can I verify a batch? | Review the product SKU, batch number, current COA, product documentation, and applicable laboratory records. |
| Can it be compared with other research peptides? | Yes. Researchers may compare the formulation with CJC-1295, Ipamorelin, Tesamorelin, and other compounds according to a defined research objective. |
Customer Reviews
| Rating | Summary |
| ⭐⭐⭐⭐⭐ | Clear labeling and professional packaging. |
| ⭐⭐⭐⭐⭐ | Product information and documentation were easy to review. |
| ⭐⭐⭐⭐⭐ | Straightforward ordering and fulfillment experience. |
| ⭐⭐⭐⭐☆ | Product arrived securely packaged with clear identification. |
Overall Rating: Customer reviews should reflect actual verified purchases and independently recorded feedback.
Related products
HGH 191AA (Somatropin)
Ipamorelin 10mg
